Novant Health, UNC Health, UNC School of Medicine announce agreement to partner across North Carolina

Novant Health, UNC Health and UNC School of Medicine have reached an agreement to expand medical education, research and clinical services to Novant Health facilities and other locations across North Carolina.

This partnership will expand the recently approved relationship between these organizations in New Hanover County to include Mecklenburg, Forsyth and other counties, with an additional focus to find innovative solutions to enhance care in rural areas.

The partnership will begin with locating a UNC School of Medicine branch campus at Novant Health Presbyterian Medical Center in Charlotte and will enhance and serve as an important training site for learners. It also gives more students access to learn at the best medical school for primary care in the country, according to U.S. News & World Report, and will expand the pipeline for high-quality physicians available to serve North Carolinians. In addition, the expansion of UNC School of Medicine’s Kenan Primary Care Medical Scholars Program will train more students to work in rural and under-resourced communities with enhanced training for care in those communities across North Carolina.

Additionally, clinical trials and studies from UNC School of Medicine’s world-renowned researchers will provide new treatment options for patients in Novant Health facilities.

Collaboration on population health has the potential to make a tremendous impact on the health of North Carolina. Together, through advanced analytics and proven population health strategies, more data will allow these partners to address community health challenges, such as COVID-19, opioid addiction, social determinants of health and health equity, to name a few.

“I am pleased that Forsyth and Mecklenburg counties, and the surrounding communities, will benefit from a collaboration between Novant Health and UNC Health and School of Medicine,” said Carl S. Armato, Novant Health president and CEO. “Our organizations are culturally aligned and committed to delivering safe, high-quality and affordable care while improving health equity in the communities we serve. This alignment allows us to expand access to medical education and clinical research across the state.”

“I am excited for the opportunities ahead for Novant Health, UNC Health and UNC School of Medicine to build a healthier North Carolina and to train more physicians for North Carolina,” said Dr. Wesley Burks, CEO of UNC Health and dean of UNC School of Medicine. “Our partnership will impact health in North Carolina for decades to come.”

More details will be announced as the partnership is finalized.

Source Article

Read more

9Round Fitness and Sunny Days Entertainment Partner to Debut New Line of Boxing Equipment in Walmart Stores Nationwide

Fitness equipment sales grow amid coronavirus pandemic

GREENVILLE, S.C., Nov. 2, 2020 /PRNewswire/ – The world’s largest kickboxing fitness franchise, 9Round Fitness is partnering with one of South Carolina’s fastest growing companies, Sunny Days Entertainment, to bring at home workouts to the next level with a new line of boxing equipment. Currently available at Walmart.com and over 600 Walmart locations nationwide, buyers can now kick, jab and cross in confidence with 9Round branded gloves, mitts, wraps and a reflex bag.

The rollout of 9Round Equipment comes at a time when fitness equipment purchases have skyrocketed since the onset of the coronavirus pandemic. According to a Yelp report, consumer interest in fitness and exercise equipment is up by 437 percent since March 10th.

“We’re thrilled to be able to partner with 9Round, bringing a quality product to consumers at a time when we know they are looking for it most,” says Rick Mershon, SVP of Sales and Marketing at Sunny Days Entertainment. “9Round Fitness has built an outstanding reputation nationwide not only as a fitness company but also as a brand, and that is very apparent through the initial consumer response to the products.”

Each item includes a pass for one free workout at a local 9Round studio of choice.

For more information visit www.9round.com.

About Sunny Days Entertainment

Established in 2012, Sunny Days Entertainment, LLC comprises a core group of toy industry veterans with the mission of solving issues for retailers while providing ultra-fun, value added products to consumers.

Sunny Days Ent. focus is to enhance the experience for consumers with affordable products. The Sunny Days line includes: Maxx Action Vehicles, Maxx Bubbles, Pop-n-Play Tents, Ravel Tales and more!

About 9Round

Founded in 2008 by professional kickboxer Shannon Hudson and his wife, Heather, 9Round is a specialized fitness center that brings kickboxing fitness training to the average person in a 30-minute, trainer-guided, full-body circuit format. The program is developed around a proprietary and copyrighted system of nine challenging workout stations created by Shannon himself. Since the workouts occur on a continuous circuit throughout the day, there are no scheduled class times. Members utilize 9ROUND PULSE, the brand’s wearable heart rate technology, to track effort, heart rate, calories burned and workout time during each 9Round session. Today, there are nearly 750 9Round locations open and operating throughout 41 states and in 19 countries including Canada, Costa Rica, Australia, Argentina, Guatemala, India, Japan, Jordan, Kuwait, Lebanon, Mexico, Ecuador, New Zealand, Saudi Arabia, Singapore, Spain, the United Arab Emirates, the United Kingdom and the United States. For more information, please visit www.9round.com.

SOURCE Sunny Days Entertainment, LLC

Source Article

Read more

JetBlue and Northwell Direct Partner to Provide Long-Term Health Solutions to COVID-19

Northwell Direct and JetBlue, New York’s Hometown Airline, (NASDAQ: JBLU) today announced that they are partnering to provide the airline with a comprehensive set of COVID-19 services and programs to support its crewmembers (employees) across JetBlue’s operation and add a clinical layer to the airline’s Safety From the Ground Up program.

The customized set of solutions from Northwell Direct – a Northwell Health company that provides a broad range of health care solutions to employers in the tri-state area – will support JetBlue as it considers testing approaches for its teams in New York City, clinical concierge services for crewmembers, and consulting and advisory services for JetBlue’s leadership. The program, which is expected to evolve and expand based on needs, is designed to detect and prevent COVID-19 and to aid in the recovery of the airline industry.

The suite of services and the ongoing evolution of the program will collaboratively be designed by clinical experts at Northwell Health, which has treated over 93,000 patients with COVID-19, and JetBlue’s leadership, and are based on science and the latest medical knowledge around COVID-19 and the specific needs of the company’s crewmembers. Tests conducted as part of any JetBlue programs will be processed by Northwell Health Labs, which has invested more than $30 million in COVID-19 testing equipment and supplies since the start of the pandemic – more than any other hospital-based lab in the country.

In addition, the program allows JetBlue to offer tri-state crewmembers 24/7 access to expert guidance and assistance with questions or concerns about the virus. These clinical concierge services provided by Northwell Health Solutions, Northwell’s care management arm, if appropriate, will also be able to provide fast and seamless navigation to care. These crewmembers will also have access to Northwell Health’s COVID Ambulatory Resource Support (CARES) program, which offers hospital-level care in the safety and comfort of home.

“JetBlue’s leaders reached out to Northwell Direct because they believe, as we do, that the path to recovery is built on a foundation of health and safety,” said Nick Stefanizzi, CEO of Northwell Direct. “We’re proud to partner with them in supporting their crewmembers and in working to restore this vital sector of the economy.”

The arrangement also provides JetBlue leadership with consulting and advisory services from Northwell Health clinical leaders to ensure corporate strategies are evidence-based and to take advantage of the latest advances in the fight against the new coronavirus. The multi-layered set of protective strategies complement JetBlue’s extensive Safety from the Ground Up program, which, along with maintaining healthy crewmembers, focuses on travel flexibility, clean air and surfaces, and more space with fewer touchpoints.

“Keeping our crewmembers healthy is an important pillar of our Safety from the Ground Up program. By partnering with a healthcare leader like Northwell, we are leveraging their experience to provide our crewmembers with confidence that they are healthy,” said Joanna Geraghty, president and chief operating officer, JetBlue. “Our crewmembers are doing an exceptional job in these challenging times, and are

Read more

111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine

SHANGHAI, Oct. 15, 2020 /PRNewswire/ — On September 24, 111, Inc. (the “Company” or “111″) and Guangzhou Xiangxue Pharmaceutical Co., Ltd. (“Xiangxue Pharmaceutical”) officially signed a strategic partnership agreement (the “Agreement”) to deepen collaboration to further develop the “Internet + Medicine” model for China’s traditional Chinese medicine industry.

Per the Agreement, 111 will become an omni-channel commercialization partner of Xiangxue Pharmaceutical. Through the integration of Smart Supply Chain, digital marketing, data capabilities, and cloud services, Xiangxue Pharmaceutical will be able to promote its abundant traditional Chinese medicine products into new markets through online and offline platforms, as well as expanding into existing markets.

As the pioneer in “Internet + Medicine” platform, 111 has built China’s largest digital healthcare platform that combines both online and offline channels covering 280,000 pharmacies nationwide. In the often underserved tier 3-6 cities, 111 covers over 63% of retail pharmacies. The Agreement aims to combine the strength of 111′s omni-channel drug commercialization platform and Xiangxue Pharmaceutical’s expansive portfolio of products to drive the growth of traditional Chinese medicine. Both companies are excited to embark on this symbiotic partnership that aims further strengthen 111′s capabilities of connecting pharmaceutical companies with patients in need of their medicine.

Mr. ZHU Pengcheng, Co-COO of 111, commented that he has full confidence in this mutually beneficial partnership that leverages the expertise of both companies to service and promote the traditional Chinese medicine industry by combining 111′s leading digital healthcare platform and Xiangxue Pharmaceutical’s innovative product line. The two parties will collaborate in big data application, digital marketing of traditional Chinese medicine, brand building, and patient health management to optimize operations and better serve patients’ needs.

Mr. TAN Guanghua, General Manager of the Marketing Center of Xiangxue Pharmaceutical, commented that 111, as China’s leading digital healthcare platform, has tremendous competitive advantages in its technology-enabled Smart Supply Chain, omni-channel drug commercialization capabilities, and smart technology and integrated online-offline infrastructure that leverages the latest in AI, cloud-based solutions, and big data. The Agreement combines the expertise of both companies and he has full confidence that the strategic partnership will be a success in achieving significant annual sales growth for Xiangxue Pharmaceutical.

About Xiangxue Pharmaceutical

Xiangxue Pharmaceutical is specialized in the health industry, covering fields such as traditional Chinese medicine decoction pieces, Chinese patent medicine, functional healthcare products, biomedical engineering, and life science research. It has built large GAP medicinal materials planting bases and GMP production bases, building an integrated industrial chain that includes traditional Chinese medicine resources development, new drug R&D and production, advanced manufacturing of traditional Chinese medicine, and modern logistics and distribution. The company has become a leading traditional Chinese medicine modernization company with proprietary intellectual property rights, its brands and self-dependent innovation ability.

About 111, Inc.

111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading digital healthcare platform committed to digitally connecting patients with healthcare products and services in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy,

Read more